Literature DB >> 15850921

Results of breast conservation therapy from a single-institution community hospital in Hawaii with a predominantly Japanese population.

Mark Kanemori1, Maria Prygrocki.   

Abstract

PURPOSE: To evaluate the outcome data from breast conservation therapy performed at the Kuakini Medical Center in Honolulu, Hawaii. The remarkably low rates of recurrence found in this study prompted a review of the literature and evaluation of the prognostic factors that may explain these results. METHODS AND MATERIALS: The data from patients with Tis, T1 or T2 breast tumors, treated with lumpectomy and radiotherapy during the 12-year period between January 1990 and December 2001 were retrospectively reviewed and compared to results found in national publications.
RESULTS: Current follow-up data was available in 97.1% of patients who met these criteria, identifying a total of 896 patients who were analyzed in this study. With a median follow-up exceeding 6 years, the local in-breast failure rate was 0.67%. Survival data was superior to the National Cancer Data Base for each stage of disease.
CONCLUSION: This low rate of local relapse is extraordinary and unmatched by the published results generally cited in the literature. The findings are consistent with other studies reporting unusually low rates of breast cancer recurrence in patients of Japanese ancestry.

Entities:  

Mesh:

Year:  2005        PMID: 15850921     DOI: 10.1016/j.ijrobp.2004.08.054

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  3 in total

1.  Breast conservative therapy in east part of China: a retrospective cohort study.

Authors:  Jiang Fan; Lei Wang; Xiao-Jin Wang; Jiong Wu; Jing-Song Lu; Gen-Hong Di; Kun-Wei Shen; Qi-Xia Han; Bang-Ling Liu; Zhen-Zhou Shen; Zhi-Ming Shao
Journal:  J Cancer Res Clin Oncol       Date:  2006-06-02       Impact factor: 4.553

2.  The consumption of seaweed as a protective factor in the etiology of breast cancer: proof of principle.

Authors:  Jane Teas; Sylvia Vena; D Lindsie Cone; Mohammad Irhimeh
Journal:  J Appl Phycol       Date:  2012-11-10       Impact factor: 3.215

Review 3.  Soy isoflavones, estrogen therapy, and breast cancer risk: analysis and commentary.

Authors:  Mark J Messina; Charles E Wood
Journal:  Nutr J       Date:  2008-06-03       Impact factor: 3.271

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.